Cincinnati, OH, May 9, 2013 (Marketwired) – Triplefin, an industry leader providing pharmaceutical marketing support solutions, including patient assistance programs; patient reimbursement support services; traditional and alternative Rx sampling; and patient adherence solutions, is celebrating its success at winning first place in the ‘Other Healthcare’, > $100 million category at the DxMA Creative Communications Awards for its ‘Connections’ brand identity campaign developed by Excitant Healthcare Advertising.
The ‘Connections’ brand identity campaign, which was unveiled in September 2012, was designed to illuminate Triplefin’s brand support capabilities and commitment to assisting pharmaceutical manufacturing companies in successfully removing patient barriers to Rx brand access and adherence and connecting more patients, physicians, and payers to pharmaceutical brands. The tagline, “Removes barriers. Connects patients. Grows brands.” reaffirms this commitment.
“We are pleased by the outstanding, creative work done by Excitant and share this honor with them. The ‘Connections’ campaign has been a great success and has increased our brand awareness with the pharmaceutical industry in many ways,” said Greg LaLonde, President of Triplefin. “Our brand promise is to connect patients, providers, pharmacies, and payers to improve outcomes and to remove brand challenges with access, acquisition, and adherence. We are committed to enhancing the patient journey and maximizing our clients’ brand performance.”
Triplefin, a member of the H. D. Smith Specialty Solutions family of companies, is recognized as the premier provider of pharmaceutical marketing support solutions. For more than 30 years, Triplefin has continually helped pharmaceutical brand managers remove barriers to brand access and adherence and put prescription brands into patients’ hands…and keep them there throughout treatment.
Today, more than 45 pharmaceutical manufacturing companies (including 15 of the top 20), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced success with Triplefin’s solutions. For more information about Triplefin’s solutions, visit www.triplefin.com.